Lowest Price Guaranteed
Slides
245
Last Updated
October 2025
View Count
10048
The global legal marijuana market, valued at USD 30.18 billion in 2024, is projected to reach USD 36.03 billion in 2025 and USD 212.39 billion by 2035, representing a CAGR of 19.41% over the forecast period.
 |
Marijuana refers to the dried leaves and flowering tops obtained from Cannabis sativa or Cannabis indica plant. The leaves and flower buds have active chemical compounds, such as tetrahydrocannabinol (THC) and cannabinoids that have therapeutic effects. Marijuana is also rich in anti-inflammatory properties and antioxidants which makes it an ideal drug for pain management and relieving stress. Owing to its therapeutic efficacy, European countries and Luxembourg has legalized the cultivation and possession of medical cannabis for recreational use.
The market has been further supported by the acceptance of marijuana derivates by the FDA to treat disease and manage pain in patients with chronic conditions. Several studies have been published by research organizations and industrial players that show that medical marijuana and its derivatives can be leveraged for the treatment of disease symptoms. For instance, an article was published by the National Institute of Health highlighting that cannabis has been used for the treatment of patients with chronic pain, chemotherapy-induced nausea, Alzheimer’s disease and other neurological disorders.
With increasing usage of marijuana for disease condition management, the market is gaining exponential traction during the upcoming years. It is important to highlight here that the FDA has approved Epidiolex® for the treatment of epilepsy, contributing to the growth of industry.
In addition to growing acceptance of marijuana for medicinal purposes, many countries have legalized the usage of marijuana derivates for recreational purposes. As a result, various industrial players are dabbling into the growing field to enhance their product portfolio and increase their efforts for exploring more applications of marijuana. For instance, in June 2024, Canopy Growth announced a significant partnership with Constellation Brands to redirect product development within marijuana industry. The aim of partnership is to develop advanced cannabis-infused beverages and enhance their customer base by harnessing Canopy’s advanced products and Constellation’s skills in manufacturing beverages.
Driven by the growing research and rising usage across various industry verticals, the legal marijuana market will continue to grow at a steady rate during the forecast period.
The market report provides comprehensive information on the leading industrial players who are active across various segments as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | $36.03 Billion | |
| Market Size 2035 | $212.39 Billion | |
| CAGR (Till 2035) | 19.41% | |
| Type of Product |
|
|
| Type of Compound |
|
|
| Type of Application |
|
|
| Type of Distribution Channel |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the market report was to estimate the current size, opportunity and the market growth potential for legal marijuana, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The legal marijuana market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product (flower buds, oils, tinctures, and other products), type of compound (tetrahydrocannabinol (THC) dominant, balanced THC & CBD and cannabidiol dominant), type of application (medical and recreational), type of distribution channel (recreational stores, pharmacies, online stores and other distribution channels), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players .
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three legal marijuana market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of product, the global market is segmented into flower buds, oils, tinctures and other products. Currently, flower buds hold the highest share (more than 50%) of the legal marijuana market. Flower buds contain the highest concentration of cannabinoids including cannabidiol and tetrahydrocannabinol, which are responsible for medicinal effects and psychoactive. Additionally, dried flower buds have been used for medicinal and recreational purposes.
However, the oils segment is expected to grow at a higher CAGR during the forecast period. The oil extracted from marijuana flowers or plants are used for treating nausea, reducing anxiety and stress, which is anticipated to be a key reason for highest growth potential. Moreover, cannabidiol oil is widely adopted in making cosmetic products, such as face cream and lotions, which further bolstered the adoption of cannabidiol oil at higher rate.
The global market is distributed across various types of compounds, such as tetrahydrocannabinol (THC) dominant, balanced THC & CBD and cannabidiol dominant. According to our projection, tetrahydrocannabinol (THC)-dominant holds the highest share of the legal marijuana market, and the trend is likely to remain unchanged during the forecast period. Tetrahydrocannabinol is widely adopted for its therapeutic efficacy, such as pain-relieving, anticancer, antianxiety, antiemetic, antitumor effects and antidepressant. This therapeutic efficacy of tetrahydrocannabinol has catered attention of the industry players to develop medicinal products using this product, anticipated to be a key driver of this segment. Driven by the growing usage of tetrahydrocannabinol, this segment will continue to grow at a higher CAGR during the forecast period.
This market highlights the distribution of legal marijuana based on the type of application into medical and recreational. Among these, the medical segment dominates the industry, holding (81%) share of the market. Several factors, such as legalization of marijuana for chronic pain management and approval of drugs for the treatment are supporting the highest share of the medical segment. It is worth highlighting here that as of December 2024, medical marijuana use is legal in 38 states and the District of Columbia.
Further, recreational use of marijuana is legal in 24 states and the District of Columbia. However, recreational segment is anticipated to grow at a higher CAGR during the forecast period driven by the rising usage of marijuana for recreational purposes.
Based on the distribution channel, the global market is segmented into recreational stores, pharmacies, online stores and other distribution channels. Presently, pharmacy market holds the largest share of the overall legal marijuana market. This can be attributed to the fact that pharmacies are integrated with regulated settings to distribute medicinal marijuana products. Moreover, pharmacies are well-regulated with hospitals to dispense medicinal marijuana-based drugs.
However, with growing usage, online stores will grow at a higher CAGR during the forecast period. This can be attributed to the convenience of purchasing and affordability offered by online stores.
The global market is distributed across geographical regions, such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. According to our legal marijuana market analysis, North America accounts for the highest share (76%) of the market and is likely to remain dominant during the forecast period. This can be attributed to the regulatory support and government is legalizing the use of marijuana for both medical and recreation purposes. Furthermore, the presence of well-established players who are continually researching marijuana for technological innovations and drug development that can be used to treat a wide range of diseases is supporting the highest share.
However, in Europe and Asia-Pacific, the market is expected to witness substantial growth and is poised to grow at a higher CAGR during the forecast period. This is likely to be the result of increasing cannabis research programs and exploration of marijuana for wide range of conditions, such as neuropathies, epilepsy and cancer. It is important to highlight here that in July 2023, The “Cannabis Research Project” has been established at CSIR-IIIM (Jammu, India) through a government partnership by Canadian company. These ongoing initiatives are supporting the growing of industry in Asian countries.
The “Legal Marijuana Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities in legal marijuana industry. The market research report lays emphasis on the legal marijuana products that are being developed. Key takeaways of the market report are briefly discussed below.
Currently, the global market landscape of legal marijuana providers witnesses the presence of several well-established industry leaders who are presently focused on developing marijuana / cannabis-based products. With growing acceptance of cannabis oil and concentrates for medicinal usage and manufacturing skin care products, the market leaders are making strategic initiatives, such as collaborations and partnership for product portfolio expansion.
Some notable market players are Aurora Cannabis, Medical Marijuana, and Medtera are undertaking strategic initiatives to enhance the therapeutic usage and other applications of marijuana. However, the industrial players are primarily focusing on growth in this field. For instance, In April 2025, The Scotts Miracle-Gro transferred its wholly-owned subsidiary, Hawthorne Collective, to an independent strategic partner. Overall, the market seems highly competitive, featuring several small, mid-sized and large industrial leaders who are currently active across different segments of industry.
The market of legal marijuana is currently propelled by the increasing legalization of marijuana for recreational and medicinal purposes. It is important to highlight here that to date the FDA has approved one cannabis-derived and three cannabis-related drug products. These approved therapeutics are currently available with prescription from licensed healthcare providers.
Moreover, in July 2024, the FDA also approved Epidiolex that has purified CBD to treat seizures associated with Dravet syndrome or Lennox-Gastaunt syndrome in elder patients. Driven by the growing approval, several market leaders are aiming to increase research initiatives for enhancing the bioavailability of marijuana and psychoactive components. In addition to legalization, the rising burden of neurological and chronic conditions are the key drivers of the market.
It is important to highlight here that several research studies has been published that shows medical marijuana and its derivatives can be used for treating symptoms of diseases, such as Alzheimer’s disease, chronic pain associated with chemotherapy-induced nausea, seizures and other neurological diseases.
Although marijuana has been adopted legally for the treatment of chronic conditions, there are several challenges that need to be addressed. Some of the potential challenges are stringent regulatory guidelines associated with the approval of cannabis based medicinal products and use of marijuana inferable.
It is important to highlight here that regulatory agencies, such as the FDA and EMA have stringent policy for using marijuana in medicinal products. For instance, the psychoactive compound of marijuana THC (Tetrahydrocannabinol) if consumed in excess can cause psychoactive effects. Therefore, industrial players are required to follow strict guidelines for the development of medicinal marijuana.
In addition, the high risk of complications associated with frequent usage of marijuana, such as temporary psychosis and schizophrenia, are the key challenges that may hinder market progress.
Some of the top trends that are anticipated to drive growth in legal marijuana industry at a steady pace include continuous research and growing usage of marijuana in cosmetic products. It is interesting to highlight here that the FDA has approved Marinol® and Syndros® for the treatment of anorexia associated with weight loss in patients with AIDS in United States. These therapeutic drugs have active dronabinol (a synthetic delta-9-tetrahydrocannabinol (THC). The FDA approval has supported industrial leaders for driving research initiatives in this industry. However, the primary focus of industrial players will be on sustainability and product innovation beyond therapeutic uses.
Furthermore, marijuana or cannabidiol oil has been constantly utilized by the cosmetic industry for the development of skincare products. Marijuana has anti-inflammatory property and is rich in antioxidants. Driven by its high anti-inflammatory property, the cosmetic industry is widely used for developing skincare range that helps to reduce pimples, acne, eczema and treatment of hair fall. For instance, in February 2024, Jublee CBD introduced their first CBD skincare lines including bath salts and body butters. The ongoing efforts, the FDA approval and adoption of cannabidiol based products in other industrial verticals are the key trends that may increase the legal marijuana market growth during the forecast period.
Currently, North America is dominating the market with a share of 76%. This lucrative share is due to the supportive regulatory framework and growing awareness about medicinal benefits of marijuana. Owing to the supportive framework, this market will continue to receive investments and collaborations to promote the development of advance therapeutic drugs with marijuana. In addition, South American region, such as Colombia, Mexico and Ecuador have also legalized the use of marijuana only in limited quantities and therapeutic usage.
The global market for legal marijuana is estimated to be valued at USD 36.03 billion in 2025 and is poised to reach USD 212.39 billion by 2035. It is interesting to note here that the National Institute for Health and Care Excellence (NICE) has published Technology Appraisals to use cannabidiol (Epidyolex®) for treating resistant epilepsies. Driven by the growing appraisal and support from regulatory authorities, this market will continue to gain traction, representing a higher CAGR of 19.41% during the forecast period.
Examples of key players engaged in this field of legal marijuana (which have also been captured in this report) include AURORA CANNABIS, ABcann Medicinals, Canopy Growth, GW Pharmaceuticals, Isodiol International, Lexaria Bioscience, MARICANN, Medical Marijuana, Organigram Holdings, Tikun Olam, Tilray Brands, The Cronos Group and United Cannabis. This market report includes an easily searchable excel database of all the companies focusing on legal cannabis development.
Several recent developments have taken place in the field of medical tourism. We have outlined some of these recent initiatives below.